- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01904513
Investigating the Effects of Probiotic Yogurt on Reducing the Levels of Environmental Toxins Among School Children in Mwanza, Tanzania (PDTX)
Study Overview
Status
Intervention / Treatment
Detailed Description
A group of 60 first year students from the Lake Primary School will be recruited for inclusion into the study. After gaining consent from the child's caregiver, each child will be given a participant number and blood, urine and fecal samples will be collected from each child by qualified personnel from NIMR. Children will be randomized into two groups (n=30) to match age, sex and weight, one of which will receive a 100 g probiotic yogurt containing Lactobacillus rhamnosus GR-1 while the other group will receive an equivalent portion of milk. After 30 days of consuming the yogurt or milk, samples will again be collected.
Samples will be shipped back to London, Ontario Canada on dry ice for analysis. Blood and urine will be analyzed via high-resolution sector field inductively coupled plasma mass spectrometry (HR-SF-ICP-MS) to determine levels of toxic heavy metals (Mercury, Lead, Cadmium, Arsenic). This will be carried out by the London Health Sciences Trace Elements laboratory in Canada. Urine will also be analyzed via gas chromatography/ mass spectrometry (GC-MS) to determine levels of pesticides at the Biotron Facility (University of Western Ontario). We will also examine urine via NMR for potential host metabolic changes in response to probiotic instillation.
Bacterial community DNA samples will be extracted and analyzed to determine the gastrointestinal microbiota of the children both before and after administration of the probiotic yogurt to determine the effect of the yogurt on the gut microbiome. Briefly, DNA will be extracted with the Qiagen Stool DNA extraction kit and bacterial community 16S rRNA genes will amplified using barcoded primers specific for a variable region within the gene. The samples will be pooled and sequenced on the Ion Torrent platform (London Regional Genomics Center, Canada). Reads are then processed and analyzed using custom scripts as well as the Quantitative Insights Into Microbial Ecology (QIIME) tool, which is the leading package for microbiota analysis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mwanza, Tanzania
- National Institute for Medical Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 6-10
- Attends Lake Primary School (Mwanza, Tanzania)
Exclusion Criteria:
- Allergic to milk/ milk products
- Lactose intolerant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Probiotic
Daily consumption of yogurt supplemented with L. rhamnosus GR-1 at ~10^10 CFU/day
|
Other Names:
|
|
Other: Milk
Daily consumption of pasteurized whole milk
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Body Toxin Levels
Time Frame: Before and after the 25 day intervention period.
|
Body toxin levels (metals, pesticides) by HR-SF-ICP-MS and GC/MS.
|
Before and after the 25 day intervention period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Microbiota Composition
Time Frame: Before and after the 25 day intervention period.
|
Stool microbiota composition shifts as determined by 16S rRNA profiling.
|
Before and after the 25 day intervention period.
|
|
Microbes linked to host toxin levels
Time Frame: Initial sample collection visit
|
Microbes, as determined via 16S rRNA sequencing, associated with high toxin levels.
|
Initial sample collection visit
|
|
Changes in host metabolism due to probiotic instillation
Time Frame: Before and after the 25 day intervention period.
|
Host metabolic shifts as measured by NMR from urine
|
Before and after the 25 day intervention period.
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 102881
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lactobacillus rhamnosus GR-1
-
Azienda Ospedaliero, Universitaria PisanaCompleted
-
Baylor College of MedicineLawson Health Research Institute; Chr HansenUnknown
-
Western University, CanadaNational Institute for Medical Research, TanzaniaCompleted
-
Glac Biotech Co., LtdActive, not recruitingAllergic RhinitisTaiwan
-
National Institute for Medical Research, TanzaniaErasmus Medical Center; Lawson Health Research Institute; University of Western... and other collaboratorsUnknownHIV Infections | Diarrhea | Bacterial VaginosisTanzania
-
Baylor College of MedicineShriners Hospitals for ChildrenWithdrawn
-
Federico II UniversityRecruitingAutism Spectrum DisorderItaly
-
Duke UniversityCompletedMicrobiomeUnited States
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; St. Joseph's Health Care LondonCompleted
-
Shenzhen Hospital of Southern Medical UniversityActive, not recruitingInflammatory Bowel Disease (IBD)China